Biogen Inc Drug Patent Portfolio

Biogen Inc's Family Patents


Family Patents



Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List

Biogen Inc News

Biogen Inc. (US09062X1037): Can its neurology pipeline lead to a resurgence?

12 Apr, 2026

Biogen partners with Alloy platform to enhance the development of ASO medications - Fierce Biotech

07 Apr, 2026

Biogen Secures Two Rapidly Expanding Medications in Major Agreement with Apellis - Benzinga

31 Mar, 2026

Indian pharmaceutical company plans to offer Wegovy alternative at competitive prices, potentially up to a 60% discount.

18 Feb, 2026

See More